Literature DB >> 24794727

Mitochondria-targeted antioxidants prevent TNFα-induced endothelial cell damage.

I I Galkin1, O Yu Pletjushkina, R A Zinovkin, V V Zakharova, I S Birjukov, B V Chernyak, E N Popova.   

Abstract

Increased serum level of tumor necrosis factor α (TNFα) causes endothelial dysfunction and leads to serious vascular pathologies. TNFα signaling is known to involve reactive oxygen species (ROS). Using mitochondria-targeted antioxidant SkQR1, we studied the role of mitochondrial ROS in TNFα-induced apoptosis of human endothelial cell line EAhy926. We found that 0.2 nM SkQR1 prevents TNFα-induced apoptosis. SkQR1 has no influence on TNFα-dependent proteolytic activation of caspase-8 and Bid, but it inhibits cytochrome c release from mitochondria and cleavage of caspase-3 and its substrate PARP. SkQ analogs lacking the antioxidant moieties do not prevent TNFα-induced apoptosis. The antiapoptotic action of SkQR1 may be related to other observations made in these experiments, namely SkQR1-induced increase in Bcl-2 and corresponding decrease in Bax as well as p53. These results indicate that mitochondrial ROS production is involved in TNFα-initiated endothelial cell death, and they suggest the potential of mitochondria-targeted antioxidants as vasoprotectors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24794727     DOI: 10.1134/S0006297914020059

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  10 in total

1.  Mitochondria-targeted antioxidant SkQ1 improves impaired dermal wound healing in old mice.

Authors:  Ilya A Demyanenko; Ekaterina N Popova; Vlada V Zakharova; Olga P Ilyinskaya; Tamara V Vasilieva; Valeria P Romashchenko; Artem V Fedorov; Vasily N Manskikh; Maxim V Skulachev; Roman A Zinovkin; Olga Yu Pletjushkina; Vladimir P Skulachev; Boris V Chernyak
Journal:  Aging (Albany NY)       Date:  2015-07       Impact factor: 5.682

2.  Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium.

Authors:  Roman A Zinovkin; Valeria P Romaschenko; Ivan I Galkin; Vlada V Zakharova; Olga Yu Pletjushkina; Boris V Chernyak; Ekaterina N Popova
Journal:  Aging (Albany NY)       Date:  2014-08       Impact factor: 5.682

3.  The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation.

Authors:  Maximilian Weniger; Leonard Reinelt; Jens Neumann; Lesca Holdt; Matthias Ilmer; Bernhard Renz; Werner Hartwig; Jens Werner; Alexandr V Bazhin; Jan G D'Haese
Journal:  Oxid Med Cell Longev       Date:  2016-05-04       Impact factor: 6.543

4.  Novel Fluorescent Mitochondria-Targeted Probe MitoCLox Reports Lipid Peroxidation in Response to Oxidative Stress In Vivo.

Authors:  Konstantin G Lyamzaev; Alisa A Panteleeva; Anna A Karpukhina; Ivan I Galkin; Ekatherina N Popova; Olga Yu Pletjushkina; Bettina Rieger; Karin B Busch; Armen Y Mulkidjanian; Boris V Chernyak
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

5.  Mitochondria-targeted triphenylphosphonium-based compounds do not affect estrogen receptor α.

Authors:  Ludmila A Zinovkina; Alina K Galivondzhyan; Anastasia S Prikhodko; Ivan I Galkin; Roman A Zinovkin
Journal:  PeerJ       Date:  2020-03-25       Impact factor: 2.984

Review 6.  Mitochondria-Targeted Drugs.

Authors:  Roman A Zinovkin; Andrey A Zamyatnin
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 7.  COVID-19 and Oxidative Stress.

Authors:  B V Chernyak; E N Popova; A S Prikhodko; O A Grebenchikov; L A Zinovkina; R A Zinovkin
Journal:  Biochemistry (Mosc)       Date:  2020-12       Impact factor: 2.487

8.  Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis.

Authors:  Alexander A Andreev-Andrievskiy; Nataliya G Kolosova; Natalia A Stefanova; Maxim V Lovat; Maxim V Egorov; Vasily N Manskikh; Roman A Zinovkin; Ivan I Galkin; Anastasia S Prikhodko; Maxim V Skulachev; Alexander N Lukashev
Journal:  Oxid Med Cell Longev       Date:  2016-05-18       Impact factor: 6.543

9.  Mitochondria-Targeted Antioxidant SkQ1 Improves Dermal Wound Healing in Genetically Diabetic Mice.

Authors:  Ilya A Demyanenko; Vlada V Zakharova; Olga P Ilyinskaya; Tamara V Vasilieva; Artem V Fedorov; Vasily N Manskikh; Roman A Zinovkin; Olga Yu Pletjushkina; Boris V Chernyak; Vladimir P Skulachev; Ekaterina N Popova
Journal:  Oxid Med Cell Longev       Date:  2017-07-06       Impact factor: 6.543

10.  Mitochondria-Targeted Antioxidants SkQ1 and MitoTEMPO Failed to Exert a Long-Term Beneficial Effect in Murine Polymicrobial Sepsis.

Authors:  Pia Rademann; Adelheid Weidinger; Susanne Drechsler; Andras Meszaros; Johannes Zipperle; Mohammad Jafarmadar; Sergiu Dumitrescu; Ara Hacobian; Luisa Ungelenk; Franziska Röstel; Jozsef Kaszaki; Andrea Szabo; Vladimir P Skulachev; Michael Bauer; Soheyl Bahrami; Sebastian Weis; Andrey V Kozlov; Marcin F Osuchowski
Journal:  Oxid Med Cell Longev       Date:  2017-09-19       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.